|
Volumn 342, Issue 9, 2009, Pages 507-512
|
Synthesis and in-vitro anti-hepatitis-B virus activity of 6H-[1]benzothiopyrano[4,3-b] quinolin-10-ols
|
Author keywords
6H 1 benzothiopyrano 4,3 b quinolin 10 ols; Anti HBV activity; Synthesis
|
Indexed keywords
11 [(1H IMIDAZOL 1 YL)METHYL] 3 FLUORO 9 METHOXY 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
11 [(DIMETHYLAMINO)METHYL] 3 FLUORO 9 METHOXY 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
2 FLUORO 9 METHOXY 11 (MORPHOLINOMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
2 FLUORO 9 METHOXY 11 (MORPHOLINOMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL 5 OXIDE;
2 FLUORO 9 METHOXY 11 (PIPERIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
2 FLUORO 9 METHOXY 11 (PIPERIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL 5 OXIDE;
2,3,9 TRIMETHOXY 11 (MORPHOLINOMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
2,9 DIMETHOXY 11 (PIPERIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
3 FLUORO 9 METHOXY 11 (MORPHOLINOMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
3 FLUORO 9 METHOXY 11 (PIPERIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
3 FLUORO 9 METHOXY 11 (PYRROLIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
3 FLUORO 9 METHOXY 11 [(2 METHYL 1H IMIDAZOL 1 YL)METHYL] 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
9 METHOXY 2 METHYL 11 (PIPERIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
9 METHOXY 2,4 DIMETHYL 11 (PIPERIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
9 METHOXY 3 METHYL 11 (MORPHOLINOMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
9 METHOXY 3 METHYL 11 (PIPERIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
9 METHOXY 3 METHYL 11 (PIPERIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL 5 OXIDE;
9 METHOXY 3 METHYL 11 (PYRROLIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL;
9 METHOXY 3 METHYL 11 (PYRROLIDIN 1 YLMETHYL) 6H [1]BENZOTHIOPYRANO[4,3 B]QUINOLIN 10 OL 5 OXIDE;
ANTIVIRUS AGENT;
LAMIVUDINE;
MANNICH BASE;
UNCLASSIFIED DRUG;
ANTIVIRAL ACTIVITY;
ARTICLE;
CELL STRAIN HEPG2;
CONTROLLED STUDY;
CYTOTOXICITY;
DRUG SCREENING;
DRUG SYNTHESIS;
HEPATITIS B VIRUS;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
NONHUMAN;
PRIORITY JOURNAL;
ANTIVIRAL AGENTS;
CELL LINE;
CELL SURVIVAL;
DNA, VIRAL;
DRUG EVALUATION, PRECLINICAL;
DRUG RESISTANCE, VIRAL;
HEPATITIS B VIRUS;
HYDROXYQUINOLINES;
LAMIVUDINE;
MOLECULAR STRUCTURE;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 70149092748
PISSN: 03656233
EISSN: 15214184
Source Type: Journal
DOI: 10.1002/ardp.200900070 Document Type: Article |
Times cited : (9)
|
References (12)
|